William Blair Investment Management
SUPN icon

William Blair Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

William Blair Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-184,848
Closed -$11.1M – 481
2018
Q2 		$11.1M Sell
184,848
-49,576
-21% -$2.57M 0.04% 320
2018
Q1 		$10.7M Sell
234,424
-20,273
-8% -$846K 0.04% 303
2017
Q4 		$10.2M Buy
254,697
+62,961
+33% +$2.49M 0.04% 300
2017
Q3 		$7.67M Buy
+191,736
New +$8.3M 0.03% 327

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

William Blair Investment Management's SUPN Position: Q3 2018 in Review

William Blair Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2018, closing a stake of 184,848 shares — an estimated $11.1M sold.

William Blair Investment Management first reported a position in SUPN in Q3 2017 and held it in 4 quarters. The position peaked at $11.1M in Q2 2018. 288 funds tracked by Wall St. Rank hold SUPN as of Q3 2018.

  • William Blair Investment Management reported no remaining Supernus Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • William Blair Investment Management sold 184,848 Supernus Pharmaceuticals shares in Q3 2018, an estimated $11.1M.
  • William Blair Investment Management first reported a position in Supernus Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • William Blair Investment Management's Supernus Pharmaceuticals position peaked at $11.1M in Q2 2018.
  • 288 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2018.

Based on William Blair Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.